Table 1.
Characteristics of patients included in the study and individual characteristic of non‐adherent patients
| Patient characteristics | All patients (n = 35) | Non‐adherent patients (n = 4) | |||
|---|---|---|---|---|---|
| Patient 1 | Patient 2 | Patient 3 | Patient 4 | ||
| Female, n (%) | 9 (26) | Male | Male | Male | Male |
| Age (years) | 66 (56–73) | >65 | >65 | >65 | <65 |
| Aetiology | |||||
| Ischaemic, n (%) | 17 (49) | Ischaemic | Ischaemic | Non‐ischaemic | Ischaemic |
| Non‐ischaemic, n (%) | 18 (51) | ||||
| Symptoms | |||||
| NYHA class | |||||
| I, n (%) | 8 (23) | II | II | I | II |
| II, n (%) | 18 (51) | ||||
| III, n (%) | 9 (26) | ||||
| MLHFQ | 17 (0–41) | 33 | 15 | 13 | 20 |
| Physiological parameters | |||||
| LVEF (%) | 32 (25–37) | 24 | 29 | 19 | 25 |
| SBP (mmHg) | 122 (135–110) | 126 | 91 | 135 | 149 |
| HR (b.p.m.) | 65 (75–57) | 85 | 92 | 64 | 59 |
| BNP (ng/L) | 381 (76–514) | 392 | 392 | 59 | 76 |
| Creatinine (μmol/L) | 98 (82–139) | 186 | 210 | 101 | 74 |
| Prognostic therapy | |||||
| ACE/ARB/ARNI | 35 (100) |
Candesartan ✓ |
Candesartan ✓ |
Ramipril ✕ |
Ramipril ✕ |
| ACE‐I, n (%) | 22 (63) | ||||
| ARB, n (%) | 9 (26) | ||||
| ARNI, n (%) | 4 (11) | ||||
| Beta‐blocker, n (%) | 34 (97) |
Bisoprolol ✓ |
Bisoprolol ✕ |
Bisoprolol ✕ |
Bisoprolol ✕ |
| MRA, n (%) | 15 (43) |
Spironolactone ✕ |
Spironolactone ✕ |
Spironolactone ✕ |
Eplerenone ✕ |
| CRT, n (%) | 13 (37) | CRT‐D | CRT‐D | CRT‐D | ICD |
| ICD, n (%) | 17 (49) | ||||
ACE‐I, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor blocker–neprilysin inhibitor; BNP, brain natriuretic peptide; CRT, cardiac resynchronization therapy; CRT‐D, cardiac resynchronization therapy defibrillator; HR, heart rate; ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction; MLHFQ, Minnesota Living with Heart Failure Questionnaire; MRA, mineralocorticoid receptor antagonist; NYHA, New York Heart Association; SBP, systolic blood pressure.
Continuous data presented as mean (standard deviation) when normally distributed and median (inter‐quartile range) when non‐normally distributed. Categorical data presented as n (% of total population).